Arutselvan Natarajan

3.4k citations
80 papers · 2.5k indexed · h-index 28
Topics
Monoclonal and Polyclonal Antibodies Research (32 papers)Radiopharmaceutical Chemistry and Applications (30 papers)Cancer Immunotherapy and Biomarkers (15 papers)
Partner nations
United StatesJapanIndia

In The Last Decade

Arutselvan Natarajan

73 papers receiving 2.4k citations

Peers

Arutselvan Natarajan
Comparison fields: 5 of 102
  • Radiology, Nuclear Medicine and Imaging 934
  • Oncology 820
  • Biomedical Engineering 746
  • Molecular Biology 677
  • Immunology 469
Replace Emily B. Ehlerding with:
Emily B. Ehlerding United States
Edmund J. Keliher United States
Giulio Fracasso Italy
Greg M. Thurber United States
Sumith A. Kularatne United States
Aaron T. Mayer United States
Stefania Lanzardo Italy
Gabriela Krämer-Marek United Kingdom
R K Jain United States
Marjan Rafat United States
Arutselvan Natarajan relative to Emily B. Ehlerding United States Emily B. Ehlerding's profile →
Citations per field
00.5×1.5×
Emily B. Ehlerding · 1×
Citations per year

Countries citing papers authored by Arutselvan Natarajan

Since Specialization
Citations

This map shows the geographic impact of Arutselvan Natarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arutselvan Natarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arutselvan Natarajan more than expected).

Fields of papers citing papers by Arutselvan Natarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arutselvan Natarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arutselvan Natarajan. The network helps show where Arutselvan Natarajan may publish in the future.

Co-authorship network of co-authors of Arutselvan Natarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Arutselvan Natarajan. A scholar is included among the top collaborators of Arutselvan Natarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arutselvan Natarajan. Arutselvan Natarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 130
4 27
5 65
6 10
7 33
8 108
9 24
10 97
11 40
12 29
13 30
14 16
15 35
16 8
17 25
18 8
19 38
20 74

About Arutselvan Natarajan

Arutselvan Natarajan is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology and Allergy, having authored 80 papers that have together received 2.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (32 papers), Radiopharmaceutical Chemistry and Applications (30 papers) and Cancer Immunotherapy and Biomarkers (15 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (934 citations), Biomaterials (406 citations) and Oncology (820 citations). Arutselvan Natarajan has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Sanjiv S. Gambhir, Sally J. DeNardo, Gerald L. DeNardo, Aaron T. Mayer, Cordula Gruettner, Robert Ivkov, Laird Miers, Robert E. Reeves, Chirag B. Patel and Sydney Gordon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026